The DOI matches its Crossref record; 68 of the 68 references it cites were found in a registry or an index.
The disconnect between animal models of sepsis and human sepsis
Open accessAbstract
Frequently used experimental models of sepsis include cecal ligation and puncture, ascending colon stent peritonitis, and the i.p. or i.v. injection of bacteria or bacterial products (such as LPS). Many of these models mimic the pathophysiology of human sepsis. However, identification of mediators in animals, the blockade of which has been protective, has not translated into clinical efficacy in septic humans. We describe the shortcomings of the animal models and reasons why effective therapy for human sepsis cannot be derived readily from promising findings in animal sepsis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bone, R. C., Balk, R. A., Cerra, F. B., Dellinger, R. P., Fein, A. M., Knaus, W. A., Schein, R. M. H., & Sibbald, W. J. (1992) · Chest · doi:10.1378/chest.101.6.1644 · Cited by 13,198
Early goal-directed therapy in the treatment of severe sepsis and septic shock
Rivers, E., Nguyen, B., Havstad, S., Ressler, J., Muzzin, A., Knoblich, B., Peterson, E., & Tomlanovich, M. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa010307 · Cited by 10,743
Intensive insulin therapy in critically ill patients.
Van den Berghe, G., Wouters, P., Weekers, F., Verwaest, C., Bruyninckx, F., Schetz, M., Vlasselaers, D., Ferdinande, P., Lauwers, P., & Bouillon, R. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011300 · Cited by 9,977
Angus, D. C., Linde-Zwirble, W. T., Lidicker, J., Clermont, G., Carcillo, J., & Pinsky, M. R. (2001) · Critical Care Medicine · doi:10.1097/00003246-200107000-00002 · Cited by 8,503
Efficacy and Safety of Recombinant Human Activated Protein C for Severe Sepsis
Bernard, G. R., Vincent, J.-L., Laterre, P.-F., LaRosa, S. P., Dhainaut, J.-F., Lopez-Rodriguez, A., Steingrub, J. S., Garber, G. E., Helterbrand, J. D., Ely, E. W., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200103083441001 · Cited by 6,132
2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference
Levy, M. M., Fink, M. P., Marshall, J. C., Abraham, E., Angus, D., Cook, D., Cohen, J., Opal, S. M., Vincent, J.-L., & Ramsay, G. (2003) · Critical Care Medicine · doi:10.1097/01.ccm.0000050454.01978.3b · Cited by 5,995
The epidemiology of sepsis in the United States from 1979 through 2000
Martin, G. S., Mannino, D. M., Eaton, S., & Moss, M. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022139 · Cited by 5,841
An endotoxin-induced serum factor that causes necrosis of tumors
Carswell, E. A., Old, L. J., Kassel, R. L., Green, S., Fiore, N., & Williamson, B. (1975) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.72.9.3666 · Cited by 4,532
Shock and Tissue Injury Induced by Recombinant Human Cachectin
Tracey, K. J., Beutler, B., Lowry, S. F., Merryweather, J., Wolpe, S., Milsark, I. W., Hariri, R. J., Fahey, T. J., Zentella, A., Albert, J. D., et al. (1986) · Science · doi:10.1126/science.3764421 · Cited by 2,549
Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia
Tracey, K. J., Fong, Y., Hesse, D. G., Manogue, K. R., Lee, A. T., Kuo, G. C., Lowry, S. F., & Cerami, A. (1987) · Nature · doi:10.1038/330662a0 · Cited by 2,448 · cited 2×
“Treatment with antiTNF- or with antithrombin III markedly improved survival, reduced evidence of DIC, and reduced blood levels of proinflammatory cytokines [60–62].”
BackgroundDetection of circulating tumor necrosis factor after endotoxin administration
Michie, H. R., Manogue, K. R., Spriggs, D. R., Revhaug, A., O'Dwyer, S., Dinarello, C. A., Cerami, A., Wolff, S. M., & Wilmore, D. W. (1988) · New England Journal of Medicine · doi:10.1056/nejm198806093182301 · Cited by 1,677 · cited 2×
“proinflammatory cytokines in serum [18, 19], another parallel”
Sepsis and septic shock—A review of laboratory models and a proposal
Wichterman, K. A., Baue, A. E., & Chaudry, I. H. (1980) · Journal of Surgical Research · doi:10.1016/0022-4804(80)90037-2 · Cited by 1,459
Bone, R. C. (1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-115-6-457 · Cited by 1,368
Treatment of Septic Shock with the Tumor Necrosis Factor Receptor:Fc Fusion Protein
Fisher, C. J., Agosti, J. M., Opal, S. M., Lowry, S. F., Balk, R. A., Sadoff, J. C., Abraham, E., Schein, R. M. H., & Benjamin, E. (1996) · New England Journal of Medicine · doi:10.1056/nejm199606273342603 · Cited by 1,241
Waage, A., Halstensen, A., & Espevik, T. (1987) · The Lancet · doi:10.1016/s0140-6736(87)91728-4 · Cited by 1,096
Okusawa, S., Gelfand, J. A., Ikejima, T., Connolly, R. J., & Dinarello, C. A. (1988) · Journal of Clinical Investigation · doi:10.1172/jci113431 · Cited by 983
Opal, S. M., Fisher, C. J., Dhainaut, J.-F. A., Vincent, J.-L., Brase, R., Lowry, S. F., Sadoff, J. C., Slotman, G. J., Levy, H., Balk, R. A., et al. (1997) · Critical Care Medicine · doi:10.1097/00003246-199707000-00010 · Cited by 865
Epidemiology of sepsis: an update
Angus, D. C., & Wax, R. S. (2001) · Critical Care Medicine · doi:10.1097/00003246-200107001-00035 · Cited by 813
Hubbard, W. J., Choudhry, M., Schwacha, M. G., Kerby, J. D., Rue, L. W., Bland, K. I., & Chaudry, I. H. (2005) · Shock · doi:10.1097/01.shk.0000191414.94461.7e · Cited by 792
Fisher, C. J. (1994) · JAMA · doi:10.1001/jama.1994.03510470040032 · Cited by 790 · cited 1×
“related mortality in large clinical trials [26].”
Novel strategies for the treatment of sepsis
Riedemann, N. C., Guo, R.-F., & Ward, P. A. (2003) · Nature Medicine · doi:10.1038/nm0503-517 · Cited by 773
Self-citationTargeting C-reactive protein for the treatment of cardiovascular disease.
Pepys, M. B., Hirschfield, G. M., Tennent, G. A., Ruth Gallimore, J., Kahan, M. C., Bellotti, V., Hawkins, P. N., Myers, R. M., Smith, M. D., Polara, A., et al. (2006) · Nature · doi:10.1038/nature04672 · Cited by 672
ANIMAL MODELS OF SEPSIS AND SHOCK: A REVIEW AND LESSONS LEARNED
Deitch, E. A. (1998) · Shock · doi:10.1097/00024382-199801000-00001 · Cited by 579
Remick, D. G., Newcomb, D. E., Bolgos, G. L., & Call, D. R. (2000) · Shock · doi:10.1097/00024382-200013020-00004 · Cited by 534
SEPSIS SYNDROMES: UNDERSTANDING THE ROLE OF INNATE AND ACQUIRED IMMUNITY
Oberholzer, A., Oberholzer, C., & Moldawer, L. L. (2001) · Shock · doi:10.1097/00024382-200116020-00001 · Cited by 481
Martich, G. D., Danner, R. L., Ceska, M., & Suffredini, A. F. (1991) · The Journal of Experimental Medicine · doi:10.1084/jem.173.4.1021 · Cited by 444
Dear SIRS, I'm sorry to say that I don't like you
Vincent, J.-L. (1997) · Critical Care Medicine · doi:10.1097/00003246-199702000-00029 · Cited by 444
Echtenacher, B., Falk, W., Männel, D. N., & Krammer, P. H. (1990) · The Journal of Immunology · doi:10.4049/jimmunol.145.11.3762 · Cited by 433
Protective effects of C5a blockade in sepsis
Czermak, B. J., Sarma, V., Pierson, C. L., Warner, R. L., Huber-Lang, M., Bless, N. M., Schmal, H., Friedl, H. P., & Ward, P. A. (1999) · Nature Medicine · doi:10.1038/10512 · Cited by 404
Self-citationRisk and the Efficacy of Antiinflammatory Agents: Retrospective and Confirmatory Studies of Sepsis
Eichacker, P. Q., Parent, C., Kalil, A., Esposito, C., Cui, X., Banks, S. M., Gerstenberger, E. P., Fitz, Y., Danner, R. L., & Natanson, C. (2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200204-302oc · Cited by 341
Experimental Intra-Abdominal Abscesses in Rats: Development of an Experimental Model
Weinstein, W. M., Onderdonk, A. B., Bartlett, J. G., & Gorbach, S. L. (1974) · Infection and Immunity · doi:10.1128/iai.10.6.1250-1255.1974 · Cited by 336
Cavaillon, J.-M., Adib-conquy, M., Fitting, C., Adrie, C., & Payen, D. (2003) · Scandinavian Journal of Infectious Diseases · doi:10.1080/00365540310015935 · Cited by 336
Protective Effects of IL-6 Blockade in Sepsis Are Linked to Reduced C5a Receptor Expression
Riedemann, N. C., Neff, T. A., Guo, R.-F., Bernacki, K. D., Laudes, I. J., Sarma, J. V., Lambris, J. D., & Ward, P. A. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.1.503 · Cited by 330
Self-citationEskandari, M. K., Bolgos, G., Miller, C., Nguyen, D. T., DeForge, L. E., & Remick, D. G. (1992) · The Journal of Immunology · doi:10.4049/jimmunol.148.9.2724 · Cited by 323
Sacerdote, P. (2006) · Palliative Medicine · doi:10.1191/0269216306pm1124oa · Cited by 291
Effects of anti-C5a antibodies on the adult respiratory distress syndrome in septic primates.
Stevens, J. H., O'Hanley, P. D., Shapiro, J., Mihm, F. G., Satoh, P. S., Collins, J. A., & Raffin, T. A. (1986) · Journal of Clinical Investigation · doi:10.1172/jci112506 · Cited by 267
Astiz, M. E., & Rackow, E. C. (1998) · The Lancet · doi:10.1016/s0140-6736(98)01134-9 · Cited by 255
Role of C5a in Multiorgan Failure During Sepsis
Huber-Lang, M., Sarma, V. J., Lu, K. T., McGuire, S. R., Padgaonkar, V. A., Guo, R.-F., Younkin, E. M., Kunkel, R. G., Ding, J., Erickson, R., et al. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.2.1193 · Cited by 224
Self-citationHodgin, K., & Moss, M. (2008) · Current Pharmaceutical Design · doi:10.2174/138161208784980590 · Cited by 215
Zantl, N., Uebe, A., Neumann, B., Wagner, H., Siewert, J.-R., Holzmann, B., Heidecke, C.-D., & Pfeffer, K. (1998) · Infection and Immunity · doi:10.1128/iai.66.5.2300-2309.1998 · Cited by 206
EVALUATION OF ENDOTOXIN MODELS FOR THE STUDY OF SEPSIS
Remick, D. G., & Ward, P. A. (2005) · Shock · doi:10.1097/01.shk.0000191384.34066.85 · Cited by 202
Self-citationEdamatsu, M., & Toyoshima, Y. Y. (1996) · Zoological Science · doi:10.2108/zsj.13.235 · Cited by 180
Role of tumor necrosis factor-alpha in lipopolysaccharide-induced pathologic alterations.
Remick, D. G., Strieter, R. M., Eskandari, M. K., Nguyen, D. T., Genord, M. A., Raiford, C. L., & Kunkel, S. L. (1990) · PubMed Central · Cited by 174
Minnema, M. C., Chang, A. C. K., Jansen, P. M., Lubbers, Y. T. P., Pratt, B. M., Whittaker, B. G., Taylor, F. B., Hack, C. E., & Friedman, B. (2000) · Blood · doi:10.1182/blood.v95.4.1117.002k12_1117_1123 · Cited by 171
Song, M., & Kellum, J. A. (2005) · Critical Care Medicine · doi:10.1097/01.ccm.0000186784.62662.a1 · Cited by 169
IMMUNE DYSFUNCTION IN MURINE POLYMICROBIAL SEPSIS: MEDIATORS, MACROPHAGES, LYMPHOCYTES AND APOPTOSIS
Ayala, A., & Chaudry, I. H. (1996) · Shock · doi:10.1097/00024382-199606001-00007 · Cited by 168
van der Poll, T. (2001) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(01)00093-7 · Cited by 167
Isolation and characterization of C-reactive protein and serum amyloid P component in the rat.
de Beer, F. C., Baltz, M. L., Munn, E. A., Feinstein, A., Taylor, J., Bruton, C. J., Clamp, J. R., & Pepys, M. B. (1982) · PubMed · Cited by 158
Evolution of the TIR, Tolls and TLRs: Functional Inferences from Computational Biology
Beutler, B., & Rehli, M. (2002) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-59430-4_1 · Cited by 151
RODENT MODELS OF INTRA-ABDOMINAL INFECTION
Deitch, E. A. (2005) · Shock · doi:10.1097/01.shk.0000191386.18818.0a · Cited by 141
Singleton, K. D., & Wischmeyer, P. E. (2003) · European Surgical Research · doi:10.1159/000073387 · Cited by 139
PRECLINICAL MODELS OF SHOCK AND SEPSIS: WHAT CAN THEY TELL US?
Marshall, J. C., Deitch, E. A., Moldawer, L. L., Opal, S. M., Redl, H. R., & van der Poll, T. (2005) · Shock · doi:10.1097/01.shk.0000191383.34066.4b · Cited by 120
Immunomodulatory effects of vasoactive catecholamines.
Bergmann, M. M., & Sautner, T. (2002) · PubMed · Cited by 100
Mechanisms of acute inflammatory lung injury induced by abdominal sepsis
Neumann, B., Zantl, N., Veihelmann, A., Emmanuilidis, K., Pfeffer, K., Heidecke, C., & Holzmann, B. (1999) · International Immunology · doi:10.1093/intimm/11.2.217 · Cited by 100
Turnbull, I. R., Javadi, P., Buchman, T. G., Hotchkiss, R. S., Karl, I. E., & Coopersmith, C. M. (2004) · Shock · doi:10.1097/01.shk.0000108399.56565.e7 · Cited by 97
Changes in the Novel Orphan, C5a Receptor (C5L2), during Experimental Sepsis and Sepsis in Humans
Huber-Lang, M. S., Sarma, J. V., Rittirsch, D., Schreiber, H. A., Weiss, M., Flierl, M. A., Younkin, E. M., Schneider, M., Suger-Wiedeck, H., Gebhard, F. T., et al. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.2.1104 · Cited by 80
Self-citationAdjunctive therapy in sepsis: a critical analysis of the clinical trial programme
Cohen, J. (1999) · British Medical Bulletin · doi:10.1258/0007142991902222 · Cited by 71
Transfusion practice and nosocomial infection: assessing the evidence
Shorr, A. F., & Jackson, W. L. (2005) · Current Opinion in Critical Care · doi:10.1097/01.ccx.0000176689.18433.f4 · Cited by 55
An improved clinically relevant sepsis model in the conscious rat
Mathiak, G., Szewczyk, D., Abdullah, F., Ovadia, P., Feuerstein, G., & Rabinovici, R. (2000) · Critical Care Medicine · doi:10.1097/00003246-200006000-00043 · Cited by 46
Lipopolysaccharide Dose Response in Baboons
Haudek, S. B., Natmeßnig, B. E., rst, W. F., Bahrami, S., Schlag, G., & Redl, H. R. (2003) · Shock · doi:10.1097/01.shk.0000090843.66556.74 · Cited by 42
LARGE ANIMAL MODELS: BABOONS FOR TRAUMA, SHOCK, AND SEPSIS STUDIES
Redl, H. R., & Bahrami, S. (2005) · Shock · doi:10.1097/01.shk.0000191339.46777.63 · Cited by 38
Anti-inflammatory strategies for the treatment of sepsis
Riedemann, N. C., & Ward, P. A. (2003) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.3.2.339 · Cited by 33
Self-citationCellular and molecular mechanisms of TNF protection in septic peritonitis.
Echtenacher, B., Hültner, L., & Männel, D. N. (1997) · PubMed · Cited by 32
Impact of interleukin-12, oxidative burst, and iNOS on the survival of murine fecal peritonitis
Entleutner, M., Traeger, T., Westerholt, A., Holzmann, B., Stier, A. W., Pfeffer, K., Maier, S., & Heidecke, C.-D. (2005) · International Journal of Colorectal Disease · doi:10.1007/s00384-004-0707-0 · Cited by 29
Cecropin B Enhances Betalactams Activities in Experimental Rat Models of Gram-Negative Septic Shock
Ghiselli, R., Giacometti, A., Cirioni, O., Mocchegiani, F., Orlando, F., D’Amato, G., Sisti, V., Scalise, G., & Saba, V. (2004) · Annals of Surgery · doi:10.1097/01.sla.0000108673.25385.03 · Cited by 27
Impact of experimental peritonitis on bone marrow cell function
Barthlen, W., Zantl, N., Pfeffer, K., Heidecke, C.-D., Holzmann, B., & Stadler, J. (1999) · Surgery · doi:10.1067/msy.1999.99060 · Cited by 25
Bengtsson, REDL, SCHLAG, Høgåsen, Götze, & Mollnes (1998) · Scandinavian Journal of Immunology · doi:10.1046/j.1365-3083.1998.00433.x · Cited by 16
Mechanisms of inflammatory response syndrome in sepsis
Hoesel, L. M., & Ward, P. A. (2004) · Drug Discovery Today Disease Mechanisms · doi:10.1016/j.ddmec.2004.11.003 · Cited by 13
Self-citation
Cited by
Chen, Y., Wang, L., Kang, Q., Zhang, X., Yu, G., Wan, X., Wang, J., & Zhu, K. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000477308 · Cited by 10,679
Immunodesign of experimental sepsis by cecal ligation and puncture
Rittirsch, D., Huber-Lang, M. S., Flierl, M. A., & Ward, P. A. (2009) · Nature Protocols · doi:10.1038/nprot.2008.214 · Cited by 2,209
Self-citationHarmful molecular mechanisms in sepsis
Rittirsch, D., Flierl, M. A., & Ward, P. A. (2008) · Nature Reviews Immunology · doi:10.1038/nri2402 · Cited by 1,202
Self-citationMyeloperoxidase: a front-line defender against phagocytosed microorganisms
Klebanoff, S. J., Kettle, A. J., Rosen, H., Winterbourn, C. C., & Nauseef, W. M. (2013) · Journal of Leukocyte Biology · doi:10.1189/jlb.0712349 · Cited by 672
Animal models of sepsis and sepsis-induced kidney injury
Doi, K., Leelahavanichkul, A., Yuen, P. S. T., & Star, R. A. (2009) · Journal of Clinical Investigation · doi:10.1172/jci39421 · Cited by 580
Metadata
- Authors
- Rittirsch, D., Hoesel, L. M., & Ward, P. A.
- Venue
- Journal of Leukocyte Biology
- Publisher
- Oxford University Press (OUP)
- Published
- 2006-10-04
- Volume
- 81
- Issue
- 1
- Pages
- 137-143
- ISSN
- 0741-5400 (ISSN-L)
- 1938-3673
- OpenAlex
- W2125498567
- Cited by
- 406
- References
- 68
- FWCI
- 10.62
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.